Implementation of an infectious disease fellow-managed penicillin allergy skin testing service

Open Forum Infectious Diseases

Volumn 3, Issue 3, 2016, Pages

  Heil, Emily L ^a   Bork, Jacqueline T ^b   Schmalzle, Sarah A ^b   Kleinberg, Michael ^b   Kewalramani, Anupama ^b   Gilliam, Bruce L ^b   Buchwald, Ulrike K ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergy; Penicillin; lactam

Indexed keywords

AMOXICILLIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; ERTAPENEM; HISTAMINE; NAFCILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG USE; EDUCATION; ERYTHEMA; FEMALE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PENICILLIN ALLERGY; PENICILLIN SKIN TEST; PRICK TEST; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SKIN TEST; TRAINING; URTICARIA;

EID: 85016086375     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw155     Document Type: Article

References (27)

1. Lee CE, Zembower TR, Fotis MA, et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 2000; 160:2819-22.
2. Charneski L, Deshpande G, Smith SW. Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients. Pharmacotherapy 2011; 31:742-7.
3. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med 2000; 9:722-6.
4. Unger NR, Gauthier TP, Cheung LW. Penicillin skin testing: potential implications for antimicrobial stewardship. Pharmacotherapy 2013; 33:856-67.
5. PREPEN [product information]. Round Rock, TX: ALK-Abello, Inc.; 2009.
6. Sogn DD, Evans R, Sheperd GM, et al. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992; 152:1025-32.
7. Harris AD, Sauberman L, Kabbash L, et al. Penicillin skin testing: a way to optimize antibiotic utilization. Am J Med 1999; 107:166-8.
8. Rimawi RH, Cook PP, Gooch M, et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 2013; 8:341-5.
9. Abbo LM, Beekmann SE, Hooton TM, et al. Management of antimicrobial allergies by infectious diseases physicians. JAMA Intern Med 2013; 173:1376-7.
10. Chandrasekar P, Havlichek D, Johnson LB. Infectious diseases subspecialty: declining demand challenges and opportunities. Clin Infect Dis 2014; 59:1593-8.
11. Chandrasekar PH. Bad news to worse news: 2015 infectious diseases fellowship match results. Clin Infect Dis 2015; 60:1438.
12. The Match. Match Results Statistics. Medical Specialties Matching Program-2015. Appointment Year 2016, pp 16. Available at: www.nrmp.org. Accessed 29 April 2016.
13. Schweizer ML, Furuno JP, Harris AD, et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11:279.
14. Kim SH, Kim KH, Kim HB, et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008; 52:192-7.
15. Red Book Online [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. Updated periodically. Available at: https://www.micromedex solutions.com/micromedex2/librarian/ssl/true. Accessed 20 November 2015.
16. Infectious Diseases Society of America Emerging Infections Network Report for Query "Antibiotic Allergy Practices", 2015. Available at: http://ein.idsociety.org/. Accessed 6 August 2016.
17. Suetrong N, Klaewsongkram J. The differences and similarities between allergists and non-allergists for penicillin allergy management. J Allergy (Cairo) 2014; doi:10.1155/2014/214183.
18. Picard M, Begin P, Bouchard H, et al. Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract 2013; 1:252-7.
19. American Board of Allergy and Immunology. Diplomate Statistics as of October 2015 Available at: https://www.abai.org/statistics_diplomates.asp. Accessed 26 November 2015.
20. Raja AS, Lindsell CJ, Bernstein JA, et al. The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting. Ann Emerg Med 2009; 54:72-7.
21. Wall GC, Peters L, Leaders CB, Wille JA. Pharmacist-managed service providing penicillin allergy skin tests. Am J Health Syst Pharm 2004; 61:1271-5.
22. Salkind AR, Cuddy PG, Foxworth JW. Is this patient allergic to penicillin? JAMA 2001; 285:2498-505.
23. Blumenthal KG, Parker RA, Shenoy ES, Walensky RP. Improving clinical outcomes in patients with methicillin-sensitive Staphylococcus aureus bacteremia and reported penicillin allergy. Clin Infect Dis 2015; 61:741-9.
24. Ceron I, Munoz P, Marin M, et al. Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy. J Antimicro Chemother 2014; 69:1669-74.
25. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation 2015; 132:1-53.
26. Lin E, Saxon A, Ridel M. Penicillin allergy: value of including amoxicillin as a determinant in penicillin skin testing. Int Arch Allergy Immunol 2010; 152:313-8.
27. Geng B, Thakor A, Clayton E, et al. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol 2015; 115:33-8.